Invesco Ltd. Karuna Therapeutics, Inc. Transaction History

Invesco Ltd.

  • $453 Billion
  • Q1 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$161.01 - $317.85 $7.41 Million - $14.6 Million
-45,998 Reduced 12.6%
319,136 $101 Million
Q3 2023

Nov 13, 2023
SELL
$164.66 - $218.08 $5.01 Million - $6.63 Million
-30,423 Reduced 7.69%
365,134 $61.7 Million
Q2 2023

Aug 11, 2023
BUY
$176.32 - $240.22 $11 Million - $15 Million
62,602 Added 18.8%
395,557 $85.8 Million
Q1 2023

May 12, 2023
BUY
$161.33 - $204.36 $4.75 Million - $6.02 Million
29,454 Added 9.7%
332,955 $60.5 Million
Q4 2022

Feb 13, 2023
SELL
$191.53 - $236.82 $650,052 - $803,767
-3,394 Reduced 1.11%
303,501 $59.6 Million
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $36.4 Million - $81.5 Million
293,854 Added 2253.31%
306,895 $69 Million
Q2 2022

Aug 15, 2022
BUY
$93.97 - $143.33 $82,505 - $125,843
878 Added 7.22%
13,041 $1.65 Million
Q1 2022

May 16, 2022
BUY
$98.9 - $132.37 $46,186 - $61,816
467 Added 3.99%
12,163 $1.54 Million
Q4 2021

Feb 14, 2022
SELL
$110.64 - $159.4 $98,358 - $141,706
-889 Reduced 7.06%
11,696 $1.53 Million
Q3 2021

Nov 15, 2021
BUY
$101.2 - $125.87 $161,414 - $200,762
1,595 Added 14.51%
12,585 $1.54 Million
Q2 2021

Aug 17, 2021
BUY
$107.45 - $135.95 $534,886 - $676,759
4,978 Added 82.8%
10,990 $1.25 Million
Q1 2021

May 17, 2021
BUY
$95.46 - $133.08 $265,378 - $369,962
2,780 Added 86.01%
6,012 $723,000
Q4 2020

Feb 16, 2021
BUY
$75.23 - $109.23 $243,143 - $353,031
3,232 New
3,232 $328,000
Q3 2020

Nov 16, 2020
SELL
$71.31 - $109.74 $7.94 Million - $12.2 Million
-111,365 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$62.14 - $117.21 $6.92 Million - $13.1 Million
111,365 New
111,365 $12.4 Million

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email